Gold Sponsor

Glaukos

Glaukos (www.glaukos.com) is an ophthalmic medical technology and pharmaceutical company focused on novel therapies for the treatment of glaucoma, corneal disorders and retinal diseases.

The company pioneered Micro-Invasive Glaucoma Surgery, or MIGS, to revolutionize the traditional glaucoma treatment and management paradigm.

Glaukos launched the iStent®, its first MIGS device, in the United States in July 2012 and launched its next-generation iStent inject® device in the United States in September 2018.

In corneal health, Glaukos’ proprietary suite of single-use, bio-activated pharmaceuticals are designed to strengthen, stabilize and reshape the cornea through a process called corneal collagen cross-linking to treat corneal ectatic disorders and correct refractive conditions.

Glaukos is leveraging its platform technology to build a comprehensive and proprietary portfolio of micro-scale surgical and pharmaceutical therapies in glaucoma, corneal health and retinal disease.

Bronze Sponsor

Legacy Benefits

After years of professional training to become a qualified specialist its vital that Ophthalmologists get the right advice to protect their future income potential. Let Legacy help evaluate the best options for you.

Legacy would like to offer a free, no obligation, review of your insurance needs - business and professional.

Please see our website for details of our services: http://www.legacygroup.co.nz/ and contact Simon Rupapera for a confidential discussion - DDI 09 354 5500, 

M 021 895 114   E simon.rupapera@legacygroup.co.nz

Medix 21

Medix 21 is a New Zealand-owned leading supplier of quality, innovative and cost-effective ophthalmology products and solutions. Our patient-centric team delivers excellent service and honest advice, backed by strong clinical and technical expertise. Collaborating with clinicians and healthcare professionals we are committed to improving quality of life.

Past Sponsors